Preventive Effect of Bifidobacterium Supplementation on Neonatal Cholestasis in Preterm Neonates with Very Low Birth Weight

Table 3

Comparative analysis of the laboratory tests for the liver function at different time points between the two groups.

	Bifidobacterium group ()	Control group ()	-test
Peak total bilirubin (μmol/L)
Baseline			2.121	<0.05
5 days			2.174	<0.05
10 days			2.097	<0.05
Discharge from hospital			2.592	<0.05
Peak direct bilirubin (μmol/L)
Baseline			0.687	<0.05
5 days			2.349	<0.05
10 days			2.349	<0.05
Discharge from hospital			4.149	<0.01
Γ-Glutamine transferase (U/L)
Baseline			4.846	<0.05
5 days			5.773	<0.01
10 days			6.435	<0.01
Discharge from hospital			17.97	<0.01
Alkaline phosphatase (U/L)
Baseline			9.934	<0.01
5 days			3.851	<0.01
10 days			9.934	<0.01
Discharge from hospital			10.70	<0.01
Alkaline phosphatase (U/L)
Baseline			2.024	<0.05
5 days after admission			2.000	<0.05
10 days			2.530	<0.05
Discharge from hospital			2.500	<0.05
Total cholesterol (mmol/L)
Baseline			5.972	<0.01
5 days			6.638	<0.01
10 days			5.928	<0.01
Discharge from hospital			4.817	<0.01

Note: the independent sample -test was used to compare the means of two sets of data. was considered as significant difference between the two groups.